Supreme Court declines to review Oklahoma law regulating PBMs

Taking stock of the drug industry, from the lab to the medicine chest

June 30, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Kayla Bartkowski/Getty Images STAT+ | Supreme Court declines to review Oklahoma law regulating PBMs There are now conflicting views among appeals courts on how to interpret the issues raised in cases in Arkansas and Oklahoma. By Ed Silverman STAT+ | AbbVie snaps up CAR-T company in a deal worth $2.1 billion Capstan Therapeutics approach has stirred excitement in the CAR-T field, which has stalled in recent years due to scientific and logistical hurdles. By Allison DeAngelis Opinion: The U.S. must invest in mRNA vaccines against pandemic influenza viruses now The Trump administration recently canceled contracts to develop and produce mRNA vaccines against pandemic influenza. That could be a disaster. By Steve Osofsky Mario Tama/Getty Images STAT+ | J&J suffers a loss over 340B drug discount program J&J argued the ruling contradicts the statute and allows for the continuing abuse and potential fraud that undermines the 340B program. By Ed Silverman STAT+ | Senator launches investigation into GSK's asthma inhaler maneuvers Senator Maggie Hassan is investigating GSK's controversial asthma inhaler switch, alleging the move put the medication out of reach for some patients. By Ed Silverman STAT+ | At Aspen Ideas, a life science VC sees cause for long-term optimism despite a rocky market Owens, who turned to VC work after a big success with Grail, says despite market uncertainty, "there's many reasons to be excited about what's possible." By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser